Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when VEEA files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Delisting (new) — Company disclosed noncompliance with Nasdaq listing rules regarding board independence following director's death.
NASDAQ: VEEA VEEA INC. 8-K

Veea falls out of Nasdaq compliance after independent director's unexpected death

Filed June 4, 2026 · Period ending June 2, 2026 · ~1 min read

4 key changes 2 high relevance 1 red flag 1 section

Key Changes

  • high

    Independent director Douglas Maine unexpectedly passed away June 1, leaving Veea with only 3 of 6 independent directors, below Nasdaq's majority requirement. Company notified exchange of noncompliance June 2.

  • high

    Audit committee now has only 2 independent directors instead of required 3, creating additional governance violation beyond board-level noncompliance.

  • medium

    Compensation committee reduced to 1 independent director versus required 2, marking third area of Nasdaq rule violation from single director loss.

  • medium

    Nasdaq granted cure period until earlier of next annual meeting or May 31, 2027 (minimum November 27, 2026). Stock continues trading normally during cure period.

Summary

Veea disclosed it has fallen out of compliance with multiple Nasdaq governance requirements following the unexpected death of independent director Douglas Maine on June 1, 2026. Maine's passing reduced the board's independent directors to three out of six total members, below the required majority.

The loss simultaneously created violations in both the audit committee (now 2 independent members versus required 3) and compensation committee (now 1 versus required 2). For retail investors, this represents a governance crisis that could lead to delisting if not resolved.

While Nasdaq has granted a cure period extending to May 31, 2027 or the next annual meeting (whichever comes first), the company provided no assurance it will successfully regain compliance. The stock continues trading normally during this period. Investors should monitor whether Veea appoints qualified independent directors before the November 27, 2026 minimum deadline. Failure to cure could trigger delisting proceedings, potentially forcing the stock to trade on less liquid over-the-counter markets and limiting institutional ownership.

Section-by-Section Diff

Event · Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule

~600 words

Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule filed; see Key Changes for terms.

3 Added
Added Director death and board composition high

Added in current filing · verify on EDGAR →

On June 1, 2026, Douglas Maine, a member of the Board, the audit committee and the compensation committee, unexpectedly passed away.

Independent director Douglas Maine unexpectedly passed away on June 1, 2026. He served on the Board, audit committee, and compensation committee. His death has immediate governance implications for the company's Nasdaq listing compliance.

Added Nasdaq board independence noncompliance high

Added in current filing · verify on EDGAR →

on June 2, 2026, Veea, Inc. (the “Company”) notified the Nasdaq Stock Market LLC (“Nasdaq”) that the Company is no longer in compliance with the majority independent director requirement under Nasdaq Listing Rule 5605(b) (1), because the Company’s Board of Directors (the “Board”) is currently comprised of six directors, three of them which are “independent directors” as that term is defined under the applicable Nasdaq Rules.

The company notified Nasdaq it no longer meets the majority independent director requirement. The Board has six directors, but only three are independent, falling short of the required majority. This violates Nasdaq Listing Rule 5605(b)(1).

Added Compensation committee noncompliance medium

Added in current filing · verify on EDGAR →

the Company is no longer in compliance with the compensation committee requirement under Nasdaq Listing Rule 5605(d) (2) (A) that there be at least two “independent directors” serving on the compensation committee as there is currently only one “independent director” serving on the compensation committee.

The compensation committee now has only one independent director instead of the required two. This is the third area of Nasdaq governance noncompliance resulting from Mr. Maine's death.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify